Blog
RSS FeedPosted by Michael Wonder on 14 Sep 2022
ATAGI update following COVID-19 meeting (7 September 2022)
14 September 2022 - An update from the Australian Technical Advisory Group on Immunisation following their meeting on 7 September 2022. ...
Posted by Michael Wonder on 12 Sep 2022
ATAGI statement on use of the Moderna bivalent original/Omicron vaccine
12 September 2022 - A statement from the Australian Technical Advisory Group on Immunisation regarding COVID-19 Moderna Spikevax Bivalent Original/Omicron BA.1 ...
Posted by Michael Wonder on 08 Sep 2022
COVID-19 vaccine safety report (8 August 2022)
8 September 2022 - To 4 September 2022, the TGA has received 699 reports which have been assessed as likely to ...
Posted by Michael Wonder on 07 Sep 2022
Statement by President Biden on FDA and CDC authorising updated COVID-19 vaccines
6 September 2022 - This week, we begin a new phase in our COVID-19 response. We are launching a new ...
Posted by Michael Wonder on 06 Sep 2022
ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines
6 September 2022 - The European Centre for Disease Prevention and Control and the European Medicines Agency have issued a ...
Posted by Michael Wonder on 03 Sep 2022
ATAGI update following weekly COVID-19 meeting (31 August 2022)
2 September 2022 - An update from the Australian Technical Advisory Group on Immunisation following their weekly meeting on 31 August ...
Posted by Michael Wonder on 29 Aug 2022
FDA expected to authorise Moderna, Pfizer-BioNTech Omicron boosters
29 August 2022 - The move would set the stage for the Biden administration to begin offering the reformulated vaccine shortly ...
Posted by Michael Wonder on 26 Aug 2022
ATAGI update following weekly COVID-19 meeting (24 August 2022)
26 August 2022 - On Wednesday 24 August 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation. ...
Posted by Michael Wonder on 25 Aug 2022
Novavax vaccine for adolescents aged 12-17 years
25 August 2022 - The Australian Technical Advisory Group on Immunisation has evaluated data on immunogenicity, efficacy, safety, and international ...
Posted by Michael Wonder on 22 Aug 2022
EMA’s Emergency Task Force advises on intradermal use of Imvanex/Jynneos against monkeypox
19 August 2022 - EMA’s Emergency Task Force (ETF) has reviewed data on the monkeypox vaccine Imvanex used as an ...
Posted by Michael Wonder on 15 Aug 2022
ATAGI recommends COVID-19 vaccine use in some children aged 6 months to 4 years
12 August 2022 - From 5 September 2022, the Australian Technical Advisory Group on Immunisation recommends COVID-19 vaccination for children aged ...
Posted by Michael Wonder on 11 Aug 2022
COVID-19 vaccine safety report (11 August 2022)
11 August 2022 - To 7 August 2022, the TGA has received 665 reports which have been assessed as likely to ...
Posted by Michael Wonder on 08 Aug 2022
Monkeypox vaccines: here’s how many have been shipped and where as White House declares public health emergency
8 August 2022 - The US Government has shipped more than 602,000 doses of Jynneos monkeypox vaccines—the only shot specifically approved ...
Posted by Michael Wonder on 08 Aug 2022
Monkeypox vaccines have arrived in Victoria. Here's how the rollout will work.
9 August 2022 - As concern about how to curb monkeypox continues at a global level, the first few thousand ...
Posted by Michael Wonder on 05 Aug 2022
FDA considering dividing Jynneos doses into fifths to increase vaccine supply
5 August 2022 - The Biden administration is considering splitting doses of the smallpox vaccine, which are being used to ...